To lay the groundwork for the April 26 Circulatory System Devices advisory panel meeting, the FDA has made trial results of Cameron Healths subcutaneous implantable cardioverter-defibrillator system (S-ICD), the first not to require implantation of an electrode on or in the heart, available to the public.